Cristina Tomassini

Cristina Tomassini

Associate, Corporate

Bio

Cristina Tomassini focuses on cross-border corporate transactions, including public and private mergers and acquisitions and selected capital markets transactions. She also is part of Skadden’s Italian practice that repeatedly has been named Best Italian Desk by TopLegal.

Ms. Tomassini’s experience includes advising:

  • DSV A/S in its US$4.6 billion acquisition of The Panalpina Group;
  • Barclays Bank PLC, HSBC Bank plc and J.P. Morgan Securities plc as lead underwriters in the Republic of Italy’s offering of US$7 billion of fixed-rate global notes with maturities of five, 10 and 30 years registered under Schedule B of the U.S. Securities Act;
  • TriRX Pharmaceuticals Services LLC in its acquisition of Merck’s French manufacturing and packaging operations of its Animal Health business;
  • L’Occitane International S.A. in connection with its acquisition of the Elemis Group for US$900 million from U.S. private equity seller L Catterton;
  • F.I.L.A. (Fabbrica Italiana Lapis e Affini S.p.A.) in connection with, inter alia:
    • the US$340 million acquisition of Pacon Holding Company from Mason Wells Inc. by its subsidiary Dixon Ticonderoga Company;
    • its €100 million Rule 144A/Regulation S rights offering of ordinary shares; and
    • its initially unsolicited, but subsequently agreed upon, acquisition of Canson Group from Groupe Hamelin S.A.;
  • The Middleby Corporation in connection with, inter alia:
    • its acquisition of Firex S.r.l. and Ve.Ma.C. S.r.l.; and
    • its US$1 billion acquisition of Taylor Company from UTC Climate, Controls & Security;
  • Nokia in its agreement to transition its Gainspeed portfolio, along with all supporting technology and assets, to Vecima Networks;
  • Reichhold, Inc. in its merger with Polynt Group S.a r.l. The newly formed company will be jointly owned by funds managed by Black Diamond Capital Management, L.L.C. and Investindustrial;
  • Reichhold SAS in the sale of a composites resin manufacturing business based in Etain, France, to Ashland France SAS;
  • Avara Pharmaceutical Services Inc. in its acquisition of Hospira S.p.A., a leading manufacturer of medical products, from Pfizer Inc.; and
  • E. I. du Pont de Nemours and Company in securing EU approval and clearance by the Department of Justice’s Antitrust Division for its $130 billion merger with The Dow Chemical Company following an in-depth antitrust review centered on crop protection products, innovation issues and petrochemicals.

Prior to joining Skadden, Ms. Tomassini spent several years practising at a leading Italian law firm in Milan.

Credentials

Education

  • J.D. Nova Southeastern University, 2011 (magna cum laude)
  • Law Degree, Università degli Studi Roma Tre, 2011 (cum laude)

Admissions

  • New York

Languages

  • English
  • Italian

Cristina Tomassini